Company / Tangible Book Value per Share
IRONWOOD PHARMACEUTICALS INC Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
-$1.63
FY2025
5-year range
-$2.25 / $4.03
FY2021-FY2025
Trend
+15.2%
vs FY2024
Sector context
#194 of 209
Health Care
What the data says
Among 209 Health Care companies, IRONWOOD PHARMACEUTICALS INC is in the bottom 7% for tangible book value per share. Tangible Book Value per Share has fluctuated over the past 10 years, ranging from $-2.25 in FY2023 to $4.03 in FY2022.
Based on SEC 10-K filings.
-1.63 in FY2025.
Improved from $-2.25 to $-1.63 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 209This company -$1.63 Sector average $119.74
▼
-101.4% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 15.2% year-over-year.
- Ranks #194 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2022.
- Lowest tangible book value per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -2.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.63 | +15.2% |
| FY2024 | -$1.93 | +14.3% |
| FY2023 | -$2.25 | -155.8% |
| FY2022 | $4.03 | +6.7% |
| FY2021 | $3.77 | +402.6% |
| FY2020 | -$1.25 | -104.7% |
| FY2019 | -$0.61 | -233.9% |
| FY2018 | $0.45 | +613.6% |
| FY2017 | $0.06 | -86.8% |
| FY2016 | $0.48 | -41.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026